Tag: global mrna therapeutics market

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of themRNA Therapeutics Market?

The rise in long-lasting and infectious diseases is expected to support the mRNA therapeutics market. These diseases are growing due to factors like global travel and limited healthcare infrastructure. mRNA therapeutics help by prompting the body to create proteins for enhanced immune response. In October 2023, GOV.UK noted that in 2022, 94,397 people in England received HIV care, up from 91,368 in 2021. Thus, the increase in these diseases is driving the mRNA therapeutics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

#What is the Growth Potential of the mRNA Therapeutics Market, and How Will It Perform by 2034?

The mRNA therapeutics market has shown steady growth, expanding from $34.76 billion in 2024 to $36.25 billion in 2025 at a CAGR of 4.3%, attributed to financial backing for RNA medicine development, federal program growth, rare disease awareness, and more clinical trials.

The mRNA therapeutics market is expected to grow to $42.23 billion by 2029 at a CAGR of 3.9%. This growth is attributed to the increasing number of infectious diseases, more hospital visits, expanding applications, demand for personalized medicine, favorable regulations, and faster approval processes. Key trends include advancements in mRNA delivery technologies, the rise of self-amplifying mRNA platforms, and scalable manufacturing techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

What Are the Current Market Growth and Trends in themRNA Therapeutics Market That Industry Players Should Watch?

Companies in the mRNA therapeutics market are producing mRNA-based booster vaccines to address emerging viral threats. In June 2023, Gennova Biopharmaceuticals Ltd. launched GEMCOVAC-OM, India’s first mRNA booster for the Omicron variant, notable for being thermostable and needle-free.

What Are the Major Market Players Making an Impact on themRNA Therapeutics Market Growth?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

How Are the Key Segments of the mRNA Therapeutics Market Driving Opportunities and Innovations?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of themRNA Therapeutics Market?# Market Expansion?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2025, By The Business Research Company:

Bipolar Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Discover trends, market shifts, and competitive outlooks for the mrna therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The mRNA Therapeutics Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for mRNA therapeutics has been on an upward trend in the last few years. The industry size is projected to increase from $34.76 billion in 2024 to $36.25 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.3%. The historical growth can be traced back to factors such as enhanced financial backing for the development of effective drugs and vaccines, the growth of government initiatives aimed at promoting RNA-centric medicines, increased understanding of rare genetic disorders, and a surge in clinical trials.

The market size of mRNA therapeutics is anticipated to experience consistent growth in the upcoming years, expanding to a whopping $42.23 billion by the year 2029, with a compound annual growth rate (CAGR) of 3.9%. The projected growth during the forecasted timeframe is mainly attributable to factors such as rising prevalence of infectious diseases, surge in patients seeking medical attention in hospitals and clinics, widening usage of mRNA therapeutics, escalating demand for precision and personalized medicine, conducive regulatory settings, and fast-tracked approval processes. Key trends foreseen during the forecasted period are the progression in mRNA delivery technologies, swift development and adoption of mRNA vaccines, the advent of self-replicating mRNA (saRNA) platforms, the ability of mRNA manufacturing to scale and adapt, and the innovation of new mRNA modifications.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the mRNA Therapeutics Market?

The escalation of persistent and transmittable diseases is estimated to drive the progression of the mRNA therapeutics market. Persistent and transmittable diseases, which include tuberculosis, HIV/AIDS, and hepatitis, are chronic illnesses that can be passed from person to person. The increasing occurrence of these diseases is attributed to increased global travel and subpar healthcare infrastructure, leading to their proliferation and obstructing their effective control. mRNA therapeutics assist in treating persistent and communicable diseases by enabling the body to promptly generate proteins to enhance immune responses, promoting faster development of treatments and vaccines. For example, GOV.UK reported in October 2023 that in 2022, 94,397 individuals in England were diagnosed with HIV and under medical care, marking a 3% increase from the 91,368 cases in 2021. As a result, the escalating occurrence of persistent and transmittable diseases is catalyzing the expansion of the mRNA therapeutics market.

Which Primary Segments of the mRNA Therapeutics Market Are Driving Growth and Industry Transformations?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

What Are the Fastest-Growing Geographies in the mRNA Therapeutics Market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the mRNA Therapeutics Industry?

Major corporations in the mRNA therapeutics industry are prioritizing the creation of novel solutions, like mRNA-based booster vaccines, to reinforce immunity against changing virus variants. A booster vaccine based on messenger RNA (mRNA) is designed to enhance and extend immunity to a specific pathogen, typically following the primary series of vaccinations. For instance, Gennova Biopharmaceuticals Ltd., a pharmaceutical business based in India, introduced GEMCOVAC-OM, India’s first homegrown mRNA-based Omicron-tailored booster vaccine, in June 2023. The aim was to generate a vaccine that could trigger the required immune response against the SARS-CoV-2’s Omicron variant. Remarkably, GEMCOVAC-OM is thermostable, circumvents the necessity for ultra-cold chain infrastructure, and can be given with a needle-less device system, rendering it suitable for end-line deployment in India. In clinical trials, this vaccine yielded substantially greater immune responses than other vaccines, pointing to the importance of variant-focused vaccines in achieving intended immune responses.

View the full report here:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

What Parameters Are Used to Define the mRNA Therapeutics Market?

Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the mrna therapeutics market grown in recent years?

The market size for mRNA therapeutics has been on a steady rise over the recent years. The market, which will amount to $34.76 billion in 2024, is projected to increase to $36.25 billion in 2025, displaying a compound annual growth rate (CAGR) of 4.3%. The significant growth observed in the historical period can be credited to various factors such as increased financial backing for developing effective drugs and vaccines, growth in government initiatives focusing on the promotion of RNA-based medicines, heightened knowledge about rare genetic disorders, and an upsurge in clinical trials.

How is the mrna therapeutics market size expected to evolve during the forecast period?

Expectations are high for the mRNA therapeutics market to enjoy solid growth in the approaching years, reaching $42.23 billion by 2029, and exhibiting a compound annual growth rate (CAGR) of 3.9%. The factors contributing to this projection in the forecast period include a rise in infectious diseases, an increase in hospital and clinic attendance, broader uses for mRNA therapeutics, a growing preference for personalized and precision medicine, encouraging regulatory landscapes, and fast-tracked approval processes. The forecast period will also be marked by progress in mRNA delivery technologies, swift advances and integration of mRNA vaccines, the introduction of self-amplifying mRNA (saRNA) platforms, the ability to scale and adapt mRNA production, and the genesis of new mRNA modifications.

Get your mrna therapeutics market report here!

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Which key drivers are propelling the mrna therapeutics market’s growth?

The rise in persistent and transmittable diseases is anticipated to boost the expansion of the mRNA therapeutics market. Persistent and transmittable diseases, such as tuberculosis, HIV/AIDS, and hepatitis, linger for prolonged periods and may be passed from one person to another. Factors like increased global travelling and inadequate healthcare systems are leading to the growth of these illnesses, as they promote the spread and obstruct the efficient management of these diseases. mRNA therapeutics can be beneficial for these persistent and contagious diseases by swiftly allowing the body to generate proteins that enhance immune responses, thus leading to faster creation of vaccines and treatments. For instance, a UK government website, GOV.UK, in October 2023 noted that there were 94,397 people in England living with diagnosed HIV and receiving care in 2022. This is a 3% rise from the 91,368 individuals in 2021. Consequently, the growing prevalence of persistent and transmittable diseases is the driving force behind the expansion of the mRNA therapeutics market.

What are the market segments in the mrna therapeutics industry?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

Which leading companies are shaping the growth of the mrna therapeutics market?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

What are the key trends shaping the future of the mrna therapeutics market?

Key players in the mRNA therapeutics market are channeling their efforts towards the creation of innovative remedies, including mRNA-based booster vaccines, aiming to reinforce immunity against emerging viral strains. The term ‘mRNA-based booster vaccine’ implies a vaccine employing messenger RNA (mRNA) technology to augment and sustain immunity against a particular pathogen, often subsequent to the primary series of vaccination. To illustrate, Gennova Biopharmaceuticals Ltd., a pharmaceutical firm based in India, in June 2023, introduced GEMCOVAC-OM; this is India’s premier indigenous mRNA-based booster vaccine targeting the Omicron variant of SARS-CoV-2. GEMCOVAC-OM is thermostable and does not necessitate ultra-cold chain infrastructure. It is designed for administration without the need for a needle injection, facilitated through the use of a needle-free device system, making its distribution, even at the remotest locations in India, convenient. The vaccine, in clinical trials, manifested significantly better immune responses than its counterparts, highlighting the requirement for variant-specific vaccines that can induce the required immune responses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

Which geographic areas are influencing the growth of the mrna therapeutics market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Bipolar Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the mrna therapeutics market grown in recent years?

The market size for mRNA therapeutics has been on a steady rise over the recent years. The market, which will amount to $34.76 billion in 2024, is projected to increase to $36.25 billion in 2025, displaying a compound annual growth rate (CAGR) of 4.3%. The significant growth observed in the historical period can be credited to various factors such as increased financial backing for developing effective drugs and vaccines, growth in government initiatives focusing on the promotion of RNA-based medicines, heightened knowledge about rare genetic disorders, and an upsurge in clinical trials.

How is the mrna therapeutics market size expected to evolve during the forecast period?

Expectations are high for the mRNA therapeutics market to enjoy solid growth in the approaching years, reaching $42.23 billion by 2029, and exhibiting a compound annual growth rate (CAGR) of 3.9%. The factors contributing to this projection in the forecast period include a rise in infectious diseases, an increase in hospital and clinic attendance, broader uses for mRNA therapeutics, a growing preference for personalized and precision medicine, encouraging regulatory landscapes, and fast-tracked approval processes. The forecast period will also be marked by progress in mRNA delivery technologies, swift advances and integration of mRNA vaccines, the introduction of self-amplifying mRNA (saRNA) platforms, the ability to scale and adapt mRNA production, and the genesis of new mRNA modifications.

Get your mrna therapeutics market report here!

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Which key drivers are propelling the mrna therapeutics market’s growth?

The rise in persistent and transmittable diseases is anticipated to boost the expansion of the mRNA therapeutics market. Persistent and transmittable diseases, such as tuberculosis, HIV/AIDS, and hepatitis, linger for prolonged periods and may be passed from one person to another. Factors like increased global travelling and inadequate healthcare systems are leading to the growth of these illnesses, as they promote the spread and obstruct the efficient management of these diseases. mRNA therapeutics can be beneficial for these persistent and contagious diseases by swiftly allowing the body to generate proteins that enhance immune responses, thus leading to faster creation of vaccines and treatments. For instance, a UK government website, GOV.UK, in October 2023 noted that there were 94,397 people in England living with diagnosed HIV and receiving care in 2022. This is a 3% rise from the 91,368 individuals in 2021. Consequently, the growing prevalence of persistent and transmittable diseases is the driving force behind the expansion of the mRNA therapeutics market.

What are the market segments in the mrna therapeutics industry?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

Which leading companies are shaping the growth of the mrna therapeutics market?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

What are the key trends shaping the future of the mrna therapeutics market?

Key players in the mRNA therapeutics market are channeling their efforts towards the creation of innovative remedies, including mRNA-based booster vaccines, aiming to reinforce immunity against emerging viral strains. The term ‘mRNA-based booster vaccine’ implies a vaccine employing messenger RNA (mRNA) technology to augment and sustain immunity against a particular pathogen, often subsequent to the primary series of vaccination. To illustrate, Gennova Biopharmaceuticals Ltd., a pharmaceutical firm based in India, in June 2023, introduced GEMCOVAC-OM; this is India’s premier indigenous mRNA-based booster vaccine targeting the Omicron variant of SARS-CoV-2. GEMCOVAC-OM is thermostable and does not necessitate ultra-cold chain infrastructure. It is designed for administration without the need for a needle injection, facilitated through the use of a needle-free device system, making its distribution, even at the remotest locations in India, convenient. The vaccine, in clinical trials, manifested significantly better immune responses than its counterparts, highlighting the requirement for variant-specific vaccines that can induce the required immune responses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

Which geographic areas are influencing the growth of the mrna therapeutics market?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Bipolar Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of themRNA Therapeutics Market?

The rise in long-lasting and infectious diseases is expected to support the mRNA therapeutics market. These diseases are growing due to factors like global travel and limited healthcare infrastructure. mRNA therapeutics help by prompting the body to create proteins for enhanced immune response. In October 2023, GOV.UK noted that in 2022, 94,397 people in England received HIV care, up from 91,368 in 2021. Thus, the increase in these diseases is driving the mRNA therapeutics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

#What is the Growth Potential of the mRNA Therapeutics Market, and How Will It Perform by 2034?

The mRNA therapeutics market has shown steady growth, expanding from $34.76 billion in 2024 to $36.25 billion in 2025 at a CAGR of 4.3%, attributed to financial backing for RNA medicine development, federal program growth, rare disease awareness, and more clinical trials.

The mRNA therapeutics market is expected to grow to $42.23 billion by 2029 at a CAGR of 3.9%. This growth is attributed to the increasing number of infectious diseases, more hospital visits, expanding applications, demand for personalized medicine, favorable regulations, and faster approval processes. Key trends include advancements in mRNA delivery technologies, the rise of self-amplifying mRNA platforms, and scalable manufacturing techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205

What Are the Current Market Growth and Trends in themRNA Therapeutics Market That Industry Players Should Watch?

Companies in the mRNA therapeutics market are producing mRNA-based booster vaccines to address emerging viral threats. In June 2023, Gennova Biopharmaceuticals Ltd. launched GEMCOVAC-OM, India’s first mRNA booster for the Omicron variant, notable for being thermostable and needle-free.

What Are the Major Market Players Making an Impact on themRNA Therapeutics Market Growth?

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

How Are the Key Segments of the mRNA Therapeutics Market Driving Opportunities and Innovations?

The mRNA therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of themRNA Therapeutics Market?# Market Expansion?

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2025, By The Business Research Company:

Bipolar Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: